west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "TONG Lin" 3 results
  • Effects of Simvastatin on Expression of NF-κB in Lung Tissue of Septic Rats

    Objective To investigate the effects of simvastatin on lung tissue in septic rats by observing the protein expression of nuclear factor kappa B ( NF-κB) and pathologic changes in lung tissue at different time points. Methods 90 healthy male Sprague-Dawley rats were randomly divided into three groups ( n =30 in each group) . All the rats received administration by caudal vein and capacity volume is 2 mL. The rats in the control group were treated with saline ( 2 mL) . The rats in the LPS group were treated with LPS ( 5 mg/kg ) . The rats in the simvastatin group were treated with LPS ( 5 mg/kg) and simvastatin ( 20 mg/kg) . Six rats in each group were killed randomly at 2, 4, 6, and 12 hours after the injection, and the right middle lobe of lung was taken out. Pathological changes of lung tissue wee investigated under light microscope. The expression of NF-κB in lung tissue was determined by immunohistochemistry ( IHC) method. Results Microscopic studies showed that there were not pathological changes in the lung tissue of rats in the control group. While in the LPS group, the alveolar spaces were narrowed and the alveolar wall were thickened. Furthermore, severe interstitial edema of lung and proliferation of epithelial cells were observed. In the simvastatin group, the degree of the infiltration of leukocytes and the lung interstitial edema were less severe than those in the simvastatin group. In the control group, the expression of NF-κB protein in most of lung tissue was negative. In the LPS group, the expression of NF-κB protein was detected at 2h, andreached the peak at 6h, then decreased at 12h. In the Simvastatin group, the NF-κB expression was significantly lower than that in the LPS group at all time points ( P lt; 0. 01) . Conclusion Simvastatin can ameliorate pathological lesions and decrease expression of NF-κB in lung tissue of septic rats.

    Release date:2016-09-13 03:50 Export PDF Favorites Scan
  • Evaluation of the Optimized Algorithm for Interventricular Intervals in Biventricular Pacing Therapy

    目的 提出双心室起搏室间间期(VV)优化新算法,并验证其合理性。 方法 选择2009年6月-2012年12月间在成都市第三人民医院心内科住院的慢性心力衰竭并接受双心室起搏是心脏再同步化治疗的患者41例,根据心脏电-机械耦联的原理,将体表心电图和超声指标的数量关系用新公式来表述,通过前瞻性自身对照研究来比较新算法与传统方法的差异。 结果 41例患者均分别采用新算法、传统超声法及腔内心电图法进行VV优化,测主动脉血流速度时间积分(AVTI)并统计耗时。经方差分析显示新算法的AVTI[(22.32 ± 3.48) cm]优于传统腔内心电图法的AVTI[(19.22 ± 3.07)cm],组间差异有统计学意义(P<0.05);而新算法的耗时[(18.80 ± 3.30)min]较传统超声法的耗时[(203.81 ± 20.12)min]明显减少,组间差异有统计学意义(P<0.01)。 结论 新算法用于双心室起搏是心脏再同步化治疗的VV优化准确、快速,具有合理性及临床推广价值。

    Release date:2016-09-07 02:38 Export PDF Favorites Scan
  • Evaluation of the Effectiveness of Mifepristone Concomitant with Misoprostol for Medical Abortion

    Objective To evaluate the effectiveness of mifepristone concomitant with misoprostol for medical abortion. Methods We searched the related original studies worldwide, and controlled prospective studies and systematic reviews based on randomized controlled trials (RCTs). Nine electronic databases were searched. Ten journals and reference lists of eligible studies were handsearched. Two reviewers independently screened the studies for eligibility, evaluated the quality, and extracted the data from eligible studies, with confirmation by cross checking. Any disputes were decided by a third person. Meta-analysis was conducted using statistical software RevMan 4.2. After heterogeneity test was done (α=0.05 ) , data without heterogeneity were pooled using a fixed effect model, and those with heterogeneity could be solved by sensitivity" analysis, subgroup analysis or random effect model. Results We found eight original trials (n = 3 348 ) that compared medical abortion with surgical abortion, nine trials (n =6 116) that investigating the effect of gestational ages on medical abortion, five trials (n = 1 934) on the use of mifepristone and two trials (n =2381 ) on intervals of administration of mifepristone and misoprostol were located. Quality of foreign studies was better than that of Chinese studies. Therate of complete abortion was higher in surgical abortion group than that in medical abortion group with odds ratio (OR) 0. 18 and 95% confidence interval (CI) 0. 11 to 0.27. The rate of incomplete abortion and abortion failure was higher in medical abortion group with OR 3.32, and 95% CI 1.79 to 6.17, OR 7.36, 95% CI 4. 17 to 12.98, respectively. The rate of complete abortion in the group with gestational age over 49 days was lower than that with gestational age under 49 days with OR 0.51 and 95% CI 0.43 to 0.61. The rate of incomplete abortion and abortion failure was higher in the group with gestational age over 49 days with OR 1.66, 95% CI 1.32 to 2.09 and OR 3.37, 95% CI 2.30 to 4. 94.There were no significant differences observed in the rates of complete abortion, incomplete abortion, abortion failed, time of expelling pregnant sac and time of menses recovery between the single and multi-dosage of mifepristone. Except for the rate of complete abortion, which was higher in 〈48h group, there was a comparable effectiveness for different intervals of mifepristone and ntisoprostol. Conclusions This review showes that it is important to improve the quality of Chinese original studies. Although the effectiveness is better in the surgical abortion group, the rate of complete abortion of medical abortion achieved is 91.6% (1 648/1 800). This is acceptable for clinicians and women who do not want to be pregnance. The rate of complete abortion is lower in the gestation over 49 days, which had a statistically difference, but little clinical significance. It is necessary to consider increasing the gestational age of medical abortion, especially for those women who have contradictions of surgical abortion or are afraid of operation. Effectiveness of single dosage of mifeprostone is similar to that ofmulti-dosage, but single dosage might be more convenient. This review suggests that shortening the interval ofmifepristone and misoprostol administration should be considered and the best and shortest interval time need to be identified with better evidence.

    Release date:2016-09-07 02:26 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content